Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 10—October 2019
CME ACTIVITY - Synopsis

Edwardsiella tarda Bacteremia, Okayama, Japan, 2005–2016

Shinya KamiyamaComments to Author , Akira Kuriyama, and Toru Hashimoto
Author affiliations: Kurashiki Central Hospital, Okayama, Japan

Main Article

Table 1

Characteristics of patients with Edwardsiella tarda bacteremia, Kurashiki Central Hospital, Okayama, Japan, 2005–2016*

Characteristic Total, N = 26 Survivors, n = 23 Patients who died within 30 d after bacteremia onset, n = 3 p value
Median age, y (IQR) [range]
75 (63–85) [45–101]
75 (64–85) [45–101]
63 (30–87) [60–87]
0.55
Sex, no. patients
M 13 11 2 1.00
F
13
12
1

Underlying disease, no. patients
Solid tumor 12 10 2 0.58
Cardiovascular disease 4 4 0 1.00
Diabetes mellitus 3 3 0 1.00
Gallstone 3 3 0 1.00
Chronic liver disease 2 1 1 0.22
Cerebrovascular disease 2 2 0 1.00
Hematologic malignancy 1 1 0 1.00
Chronic kidney disease 0 0 0 NE
Ulcerative colitis 0 0 0 NE
Crohn disease 0 0 0 NE
None 4 2 2 0.052
Other
0
0
0
NE
Behavioral/dietary risk factors, no. patients
Alcoholism 4 2 2 0.052
Exposure to raw food 3 3 0 1.00
Exposure to fresh or marine water, animal feces
1
1
0
1.00
Clinical diagnosis, no. patients
Cholangitis 9 9 0 0.53
Liver abscess 6 6 0 1.00
Enterocolitis 4 4 0 1.00
Cholecystitis 3 3 0 1.00
Spontaneous bacterial peritonitis 1 0 1 0.115
Mycotic aneurysm 1 1 0 1.00
Necrotizing fasciitis 1 0 1 0.115
Empyema 1 0 1 0.115
Febrile neutropenia 1 1 0 1.00
Osteomyelitis 1 1 0 1.00
Secondary peritonitis 1 1 0 1.00
Focus unknown 5 4 1 0.49
Receipt of chemotherapy for cancer
4
4
0
1.00
Median duration of treatment for infection, d (IQR) [range]† 12 (7–27) [1–77] 13 (8–30) [1–77] 5 (2–11) [2–11] 0.084

*IQR, interquartile range; NE, not evaluated.

Main Article

Page created: September 12, 2019
Page updated: September 12, 2019
Page reviewed: September 12, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external